Revenue growth has been uneven at 6.7% in 2026Q3 within a -6.6% to 9.6% range, while gross margin of 21.1% and operating margin of 11.4% suggest a program-mix-driven rebound from the 16.7% gross margin trough in 2025Q1 rather than structural pricing improvement.
Northrop Grumman Corporation (NOC) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 43.59B | 41.95B | 41.03B | 39.29B | 36.6B | 35.67B | 36.8B | 33.84B | 30.09B | 25.8B | 24.51B | 23.53B | 23.98B | 24.66B | 25.22B | 26.41B | 28.14B | 33.76B | 33.89B | 32.02B | 30.15B | 30.72B | 29.85B | 26.21B | 17.21B | 13.56B | 7.62B | 8.99B | 8.9B | 9.15B | 8.07B |
| Revenue Growth % | 6.51% | 2.24% | 4.44% | 7.34% | 2.62% | -3.08% | 8.74% | 12.45% | 16.63% | 5.28% | 4.17% | -1.89% | -2.77% | -2.21% | -4.52% | -6.15% | -16.63% | -0.39% | 5.84% | 6.2% | -1.87% | 2.91% | 13.92% | 52.31% | 26.91% | 77.97% | -15.31% | 1.04% | -2.74% | 13.41% | 18.38% |
| Cost of Goods Sold | 34.86B | 33.64B | 32.67B | 32.74B | 29.13B | 28.4B | 29.32B | 26.58B | 23.3B | 19.85B | 18.73B | 17.88B | 18.38B | 19.28B | 19.64B | 20.79B | 22.85B | 28.13B | 27.7B | 25.8B | 24.66B | 25.59B | 25.14B | 22.32B | 14.1B | 11.22B | 5.07B | 6.46B | 6.54B | 6.62B | 5.85B |
| COGS % of Revenue | - | 80.19% | 79.62% | 83.33% | 79.58% | 79.62% | 79.68% | 78.55% | 77.43% | 76.93% | 76.43% | 76.02% | 76.64% | 78.19% | 77.87% | 78.7% | 81.19% | 83.34% | 81.74% | 80.59% | 81.8% | 83.3% | 84.2% | 85.18% | 81.97% | 82.75% | 66.49% | 71.85% | 73.43% | 72.35% | 72.47% |
| Gross Profit | 8.73B | 8.31B | 8.36B | 6.55B | 7.47B | 7.27B | 7.48B | 7.26B | 6.79B | 5.95B | 5.78B | 5.64B | 5.6B | 5.38B | 5.58B | 5.63B | 5.29B | 5.63B | 6.19B | 6.21B | 5.49B | 5.13B | 4.72B | 3.88B | 3.1B | 2.34B | 2.55B | 2.53B | 2.37B | 2.53B | 2.22B |
| Gross Margin % | 20.02% | 19.81% | 20.38% | 16.67% | 20.42% | 20.38% | 20.32% | 21.45% | 22.57% | 23.07% | 23.57% | 23.98% | 23.36% | 21.81% | 22.13% | 21.3% | 18.81% | 16.66% | 18.26% | 19.41% | 18.2% | 16.7% | 15.8% | 14.82% | 18.03% | 17.25% | 33.51% | 28.15% | 26.57% | 27.65% | 27.53% |
| Gross Profit Growth % | - | -0.59% | 27.64% | -12.35% | 2.83% | -2.81% | 3.02% | 6.89% | 14.06% | 3.06% | 2.39% | 0.73% | 4.13% | -3.6% | -0.82% | 6.27% | -5.88% | -9.11% | -0.4% | 13.23% | 6.96% | 8.75% | 21.47% | 25.21% | 32.62% | -8.38% | 0.83% | 7.06% | -6.56% | 13.91% | 24.9% |
| Operating Expenses | 4.33B | 4.03B | 3.99B | 4.01B | 3.87B | 1.62B | 3.41B | 3.29B | 3.04B | 2.71B | 2.63B | 2.57B | 2.4B | 2.26B | 2.4B | 23.14B | 2.47B | 3.14B | 6.3B | 3.21B | 3.03B | 2.95B | 2.68B | 2.35B | 1.71B | 1.33B | 1.46B | 1.56B | 1.61B | 1.65B | 1.56B |
| OpEx % of Revenue | - | 9.61% | 9.73% | 10.22% | 10.58% | 4.53% | 9.27% | 9.72% | 10.1% | 10.51% | 10.74% | 10.91% | 10.03% | 9.15% | 9.53% | 87.6% | 8.77% | 9.31% | 18.59% | 10.02% | 10.06% | 9.61% | 8.97% | 8.95% | 9.94% | 9.85% | 19.1% | 17.38% | 18.07% | 18.04% | 19.38% |
| Selling, General & Admin | 3.94B | 4.03B | 2.89B | 3.91B | 1.14B | 227M | 3.25B | 4.29B | 2.62B | 1.48B | 2.97B | 2.57B | 2.4B | 2.26B | 2.45B | 2.35B | 2.47B | 3.14B | 3.24B | 3.21B | 3.03B | 2.95B | 2.71B | 2.35B | 1.71B | 1.33B | 1.07B | 1.17B | 1.22B | 1.23B | 1.2B |
| SG&A % of Revenue | - | 9.61% | 7.05% | 9.94% | 3.1% | 0.64% | 8.83% | 12.68% | 8.7% | 5.72% | 12.12% | 10.91% | 10.03% | 9.15% | 9.72% | 8.9% | 8.77% | 9.31% | 9.56% | 10.02% | 10.06% | 9.61% | 9.08% | 8.95% | 9.94% | 9.85% | 14.1% | 13.05% | 13.66% | 13.47% | 14.83% |
| Research & Development | 0 | 1.1B | 1.1B | 1.2B | 1.2B | 1.1B | 0 | 953M | 764M | 639M | 705M | 712M | 569M | 507M | 520M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | 2.62% | 2.68% | 3.05% | 3.28% | 3.08% | - | 2.82% | 2.54% | 2.48% | 2.88% | 3.03% | 2.37% | 2.06% | 2.06% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 2M | -1.1B | -1M | -1.09B | 1.54B | 290M | 164M | -1.95B | -341M | 596M | -1.04B | -712M | -569M | -507M | 0 | 0 | 0 | 0 | 3.06B | 0 | 0 | 0 | -35M | 0 | 0 | 0 | 381M | 389M | 393M | 418M | 367M |
| Operating Income | 4.39B | 4.28B | 4.37B | 2.54B | 3.6B | 5.65B | 4.07B | 3.97B | 3.78B | 3.3B | 3.19B | 3.08B | 3.2B | 3.12B | 3.13B | 3.28B | 2.83B | 2.48B | -111M | 3.01B | 2.45B | 2.18B | 2.04B | 1.54B | 1.39B | 1B | 1.1B | 969M | 756M | 880M | 658M |
| Operating Margin % | 10.08% | 10.2% | 10.65% | 6.46% | 9.84% | 15.84% | 11.05% | 11.73% | 12.56% | 12.79% | 13.03% | 13.07% | 13.33% | 12.66% | 12.41% | 12.4% | 10.05% | 7.36% | -0.33% | 9.39% | 8.14% | 7.09% | 6.84% | 5.87% | 8.08% | 7.41% | 14.41% | 10.77% | 8.49% | 9.61% | 8.15% |
| Operating Income Growth % | - | -2.06% | 72.25% | -29.55% | -36.28% | 39.02% | 2.42% | 5% | 14.58% | 3.32% | 3.8% | -3.75% | 2.34% | -0.22% | -4.46% | 15.88% | 13.85% | 2336.94% | -103.69% | 22.49% | 12.67% | 6.71% | 32.7% | 10.57% | 38.55% | -8.56% | 13.31% | 28.17% | -14.09% | 33.74% | 22.76% |
| EBITDA | 5.92B | 5.75B | 5.74B | 3.88B | 4.94B | 6.89B | 5.33B | 5.23B | 4.58B | 3.77B | 3.65B | 3.54B | 3.66B | 3.62B | 3.64B | 3.82B | 3.38B | 3.07B | 650M | 3.73B | 3.15B | 2.93B | 2.76B | 2.17B | 1.92B | 1.65B | 1.48B | 1.36B | 1.15B | 1.3B | 1.02B |
| EBITDA Margin % | 13.58% | 13.71% | 13.99% | 9.86% | 13.5% | 19.32% | 14.49% | 15.47% | 15.22% | 14.63% | 14.89% | 15.06% | 15.25% | 14.67% | 14.43% | 14.46% | 12.02% | 9.09% | 1.92% | 11.63% | 10.43% | 9.55% | 9.24% | 8.29% | 11.14% | 12.16% | 19.41% | 15.1% | 12.91% | 14.18% | 12.7% |
| EBITDA Growth % | 1.88% | 0.21% | 48.13% | -21.61% | -28.26% | 29.22% | 1.87% | 14.28% | 21.36% | 3.43% | 2.99% | -3.14% | 1.11% | -0.6% | -4.71% | 12.95% | 10.23% | 372% | -82.55% | 18.44% | 7.23% | 6.35% | 26.92% | 13.41% | 16.19% | 11.49% | 8.91% | 18.19% | -11.48% | 26.63% | 25.61% |
| D&A (Non-Cash Add-back) | 1.52B | 1.47B | 1.37B | 1.34B | 1.34B | 1.24B | 1.27B | 1.26B | 800M | 475M | 456M | 467M | 462M | 495M | 510M | 544M | 555M | 585M | 761M | 719M | 691M | 755M | 717M | 635M | 525M | 645M | 381M | 389M | 393M | 418M | 367M |
| EBIT | 5.89B | 5.73B | 5.47B | 2.89B | 6.34B | 7.5B | 4.32B | 2.97B | 4.3B | 4.45B | 2.98B | 3.08B | 3.2B | 3.12B | 3.18B | 3.3B | 2.63B | 2.55B | -225M | 3.02B | 2.63B | 2.2B | 1.99B | 1.47B | 1.12B | 1.03B | 1.1B | 954M | 752M | 880M | 703M |
| Net Interest Income | -656M | -665M | -621M | -545M | -506M | -556M | -593M | -528M | -562M | -360M | -301M | -301M | -282M | -257M | -212M | -221M | -269M | -281M | -295M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 656M | 665M | 621M | 545M | 506M | 556M | 593M | 528M | 562M | 360M | 301M | 301M | 282M | 257M | 212M | 221M | 269M | 281M | 295M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 842M | 788M | 646M | -191M | 2.23B | 3.29B | -337M | -1.42B | -38M | 1.01B | -270M | -286M | -259M | -260M | -165M | -193M | -232M | -217M | -257M | -320M | -178M | -113M | -391M | -413M | -111M | -306M | -123M | -207M | -443M | -229M | -271M |
| Pretax Income | 5.24B | 5.07B | 5.02B | 2.35B | 5.84B | 8.94B | 3.73B | 2.55B | 3.74B | 3.05B | 2.92B | 2.79B | 2.94B | 2.86B | 2.96B | 3.08B | 2.37B | 2.27B | -368M | 2.69B | 2.28B | 2.04B | 1.61B | 1.13B | 1.01B | 699M | 975M | 762M | 312M | 651M | 384M |
| Pretax Margin % | 12.01% | 12.08% | 12.22% | 5.97% | 15.94% | 25.06% | 10.13% | 7.53% | 12.43% | 11.82% | 11.93% | 11.86% | 12.25% | 11.61% | 11.76% | 11.67% | 8.41% | 6.71% | -1.09% | 8.39% | 7.55% | 6.65% | 5.41% | 4.32% | 5.86% | 5.16% | 12.8% | 8.47% | 3.5% | 7.11% | 4.76% |
| Income Tax | 716M | 886M | 842M | 290M | 940M | 1.93B | 539M | 300M | 513M | 1.03B | 723M | 800M | 868M | 911M | 987M | 997M | 462M | 693M | 913M | 883M | 709M | 661M | 522M | 323M | 312M | 272M | 350M | 279M | 118M | 244M | 150M |
| Effective Tax Rate % | 13.67% | 17.48% | 16.79% | 12.36% | 16.11% | 21.63% | 14.46% | 11.77% | 13.71% | 33.91% | 24.73% | 28.67% | 29.55% | 31.82% | 33.29% | 32.34% | 19.53% | 30.58% | -248.1% | 32.87% | 31.15% | 32.34% | 32.32% | 28.56% | 30.92% | 38.91% | 35.9% | 36.61% | 37.82% | 37.48% | 39.06% |
| Net Income | 4.52B | 4.18B | 4.17B | 2.06B | 4.9B | 7B | 3.19B | 2.25B | 3.23B | 2.02B | 2.2B | 1.99B | 2.07B | 1.95B | 1.98B | 2.12B | 2.05B | 1.69B | -1.26B | 1.79B | 1.54B | 1.4B | 1.08B | 866M | 64M | 427M | 608M | 467M | 194M | 407M | 234M |
| Net Margin % | 10.37% | 9.97% | 10.17% | 5.23% | 13.38% | 19.64% | 8.67% | 6.64% | 10.73% | 7.81% | 8.98% | 8.46% | 8.63% | 7.92% | 7.84% | 8.02% | 7.29% | 4.99% | -3.72% | 5.59% | 5.11% | 4.56% | 3.63% | 3.3% | 0.37% | 3.15% | 7.98% | 5.19% | 2.18% | 4.45% | 2.9% |
| Net Income Growth % | 12.47% | 0.19% | 103.02% | -58.01% | -30.11% | 119.66% | 41.86% | -30.38% | 60.25% | -8.41% | 10.55% | -3.82% | 5.99% | -1.31% | -6.61% | 3.17% | 21.77% | 233.6% | -170.5% | 16.08% | 10.14% | 29.15% | 25.17% | 1253.13% | -85.01% | -29.77% | 30.19% | 140.72% | -52.33% | 73.93% | -7.14% |
| Net Income (Continuing) | 4.52B | 4.18B | 4.17B | 2.06B | 4.9B | 7B | 3.19B | 2.25B | 3.23B | 2.87B | 2.2B | 1.99B | 2.07B | 1.95B | 1.98B | 2.09B | 1.9B | 1.57B | -1.28B | 1.8B | 1.57B | 1.4B | 1.09B | 758M | 455M | 459M | 625M | 474M | 193M | 407M | 264M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13M | 139M | 122M | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 31.74 | 29.08 | 28.34 | 13.53 | 31.47 | 43.54 | 19.03 | 13.22 | 18.49 | 11.47 | 12.19 | 10.39 | 9.75 | 8.35 | 7.81 | 7.52 | 6.82 | 5.21 | -3.77 | 5.12 | 4.37 | 3.85 | 2.97 | 2.09 | 1.84 | 2.37 | 4.29 | 3.35 | 1.40 | 2.99 | 2.08 |
| EPS Growth % | 14.03% | 2.61% | 109.46% | -57.01% | -27.72% | 128.8% | 43.95% | -28.5% | 61.2% | -5.91% | 17.32% | 6.56% | 16.77% | 6.91% | 3.86% | 10.26% | 30.9% | 238.2% | -173.63% | 17.16% | 13.51% | 29.63% | 42.11% | 13.59% | -22.36% | -44.76% | 28.06% | 139.29% | -53.18% | 43.75% | -11.86% |
| EPS (Basic) | - | 29.14 | 28.39 | 13.57 | 31.61 | 43.70 | 19.08 | 13.28 | 18.59 | 11.55 | 12.30 | 10.51 | 9.91 | 8.50 | 7.96 | 7.65 | 6.91 | 5.28 | -3.77 | 5.24 | 4.46 | 3.93 | 3.01 | 2.11 | 1.87 | 2.39 | 4.31 | 3.37 | 1.42 | 3.05 | 2.11 |
| Diluted Shares Outstanding | 142.4M | 143.8M | 147.3M | 152M | 155.6M | 160.9M | 167.6M | 170M | 174.6M | 175.6M | 180.5M | 191.6M | 212.1M | 233.9M | 253.4M | 281.6M | 301.1M | 323.3M | 334.5M | 354.3M | 358.6M | 363.2M | 365M | 408.61M | 228.82M | 172.57M | 141.76M | 139.61M | 139.07M | 136.12M | 127.23M |
| Basic Shares Outstanding | 142.1M | 143.5M | 147M | 151.5M | 154.9M | 160.3M | 167.1M | 169.3M | 173.7M | 174.4M | 178.9M | 189.4M | 208.8M | 229.6M | 248.6M | 276.8M | 296.9M | 319.2M | 334.5M | 341.7M | 345.7M | 356.5M | 359.7M | 404.74M | 224.9M | 171.13M | 141.16M | 138.78M | 137.1M | 133.44M | 125.12M |
| Dividend Payout Ratio | - | 30.92% | 28.41% | 54.28% | 21.49% | 14.03% | 29.88% | 39.15% | 25.43% | 34.19% | 29.09% | 30.3% | 27.21% | 27.92% | 27.05% | 25.64% | 26.55% | 31.97% | - | 28.16% | 26.07% | 25.64% | 29.7% | 35.22% | 320.31% | 37% | 18.75% | 23.77% | 56.19% | 25.06% | 37.18% |
Quick answers to the most common questions about buying NOC stock.
For fiscal year 2025, Northrop Grumman Corporation (NOC) reported total revenue of $41.95B. This represents a 419.8% increase compared to $8.07B in 1996.
Northrop Grumman Corporation (NOC) is profitable, generating $4.18B in net income for the fiscal year ending 2025 with a net profit margin of 10.0%.
Northrop Grumman Corporation (NOC) reported an operating income of $4.28B, resulting in an operating profit margin of 10.2%. This margin reflects the operational efficiency of the business before interest and taxes.
Northrop Grumman Corporation (NOC) generated $8.31B in gross profit for the year, representing a gross profit margin of 19.8%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Sentinel fixed-price margin compression
Metrics are mathematically derived from official filings.
Milestone-Driven Revenue Without Acceleration
Northrop's quarterly revenue growth has been uneven, ranging from -6.6% to 9.6% over the last ten quarters, with the latest period at 6.7%; according to reported income statements, this pattern suggests modest but non-accelerating top-line expansion tied to program milestones.
Revenue has trended from $10.2B in 2024Q2 to $11.1B in 2026Q3, but the path is choppy — the 2025Q1 contraction to $9.5B and the 9.6% spike in 2025Q4 ($11.7B) both appear consistent with lumpy milestone-based recognition on large programs rather than a change in underlying demand. The dispersion in growth rates implies durability of the ~2% trend cited elsewhere is questionable as a quarterly forecast; investors should treat book-to-bill and EAC revisions, not sequential revenue, as the better forward signal. The absence of accelerating growth against a favorable backlog suggests conversion timing, not order intake, is the binding constraint.
Gross Margin Rebound Masks Structural Thinness
Gross margin recovered to 21.1% in the most recent quarter from a 16.7% low in 2025Q1, and as reported in NOC's income statement, this rebound appears driven by program mix rather than structural pricing improvement.
Gross margin has oscillated in a 16.7%–21.4% band across ten quarters, clustering near 21% in seven of them, which suggests the 2025Q1 print was an outlier driven by cost or recognition timing rather than a shift in the business's earning power. Against peers, NOC's ~19.8% gross margin sits well above Lockheed Martin (10.2%) and General Dynamics (15.1%) and roughly in line with RTX (20.1%), implying a portfolio skewed toward higher-value systems rather than superior pricing power per se. Because a large share of the book is cost-plus or early fixed-price work, the ceiling on gross spread appears contractual rather than competitive, so margin upside likely requires mix shift toward mature production, not renegotiation.
Overhead Absorption Governs Operating Spread
Operating margin of 11.4% in 2026Q3 implies SG&A consumed roughly 10% of the $11.1B revenue base, and per NOC's reported figures, the operating spread has swung between 6.1% and 13.8%, indicating overhead absorption rather than gross profitability is the swing factor.
In 2025Q2, gross margin held flat at 21.4% versus 2025Q3 yet operating margin fell from 13.8% to 11.9%, a divergence that points to SG&A and program-phase spending — not gross economics — driving bottom-line variability. The 2025Q1 trough (6.1% operating margin on a 16.7% gross margin) shows how quickly thin gross spreads translate into earnings pressure when overhead is fixed. R&D is disclosed as zero in nine of ten quarters, with a single $1.1B entry in 2024Q4, so the R&D intensity of the portfolio cannot be reliably assessed from this dataset; investors should monitor whether operating leverage improves as B-21 volume scales into LRIP, since fixed cleared-labor overhead should theoretically dilute on higher units.
EPS Volatility Outpaces Underlying Operations
Diluted EPS ranged from $3.32 to $9.99 across the last ten quarters, with growth rates spanning -47.5% to 84.9%, and as EDBL-style reported figures show, such dispersion far exceeds the movement in revenue and gross profit, pointing to significant non-operational swing factors.
The 2025Q1 print of $3.32 on $481M net income (5.1% net margin) versus 2025Q4's $9.99 on $1.4B (12.2%) cannot be explained by the underlying business, which grew revenue only 9.6% in that period; the FAS/CAS pension adjustment and intangible amortization from the Orbital ATK acquisition are the more plausible mechanical drivers given their documented role in NOC's reporting. Stock-based compensation is comparatively modest at $20–54M per quarter (roughly 0.2–0.5% of revenue), so EPS dilution from equity issuance appears contained and is not a material quality concern. Net margin tracking above operating margin in certain quarters (e.g., 12.2% vs 8.9% in 2025Q4) warrants scrutiny, as it implies non-operating items are contributing disproportionately to reported profitability.
2025Q1 Trough Anchored the Recovery
The clearest inflection sits in 2025Q1, when gross margin collapsed to 16.7% and operating income fell to $573M (6.1% margin), and according to NOC's filings, every subsequent quarter has recovered to at least 19.5% gross margin and roughly 10% operating margin.
The sequential recovery into 2025Q2 — operating income jumping from $573M to $1.4B on essentially flat revenue — suggests the Q1 shortfall was a discrete cost or EAC event rather than a demand problem, making the baseline for forward margin comparisons the post-Q1 regime, not the Q1 print itself. The durability of this recovery matters: seven of the last eight quarters have held operating margin near or above 10%, which implies the cost structure stabilized once that adjustment passed. However, the single-quarter nature of the improvement means a repeat event cannot be ruled out, and investors should treat any renewed negative EAC revision as a signal the inflection has not held.
Fixed-Price Shift Could Undo Margin Gains
The bears' strongest case centers on margin durability: gross margin averaged 21.4% across recent quarters but the B-21's move into LRIP and Sentinel's cost breach may convert cost-plus tailwinds into fixed-price risk, a scenario NOC's own reported spread of 6.1%–13.8% operating margin has already shown it can absorb only unevenly.
If LRIP terms on B-21 shift materially toward fixed pricing while cleared-labor and input costs remain inflationary, the 19.8% gross margin could compress toward the 16.7% level seen in 2025Q1, and because SG&A runs near 10% of revenue, operating margin would fall disproportionately — potentially into the mid-single digits, as it did that quarter. The Nunn-McCurdy breach on Sentinel adds a second vector: cost growth on a sole-source program is contained politically, but re-baselining or stretch-outs could defer the revenue that supports current overhead absorption. The counterargument investors should weigh is that revenue growth itself remains modest (2.2% cited at the latest print) while margins rely on mix, so a growth-plus-margin narrative may be harder to sustain than the backlog headline implies; this tension warrants close monitoring of forward guidance and EAC disclosures.